Journal Articles
European Journal of Cancer
Year : 2021
Equipe HAL Paris Diderot : Connect in order to contact the contributor
https://u-paris.hal.science/hal-03236358
Submitted on : Wednesday, May 26, 2021-11:17:32 AM
Last modification on : Friday, August 5, 2022-11:55:02 AM
Cite
Katherine Francis, Val Gebski, Sarah Lord, Michael Friedlander, Eric Pujade-Lauraine, et al.. Reporting the trajectories of adverse events over the entire treatment course in patients with recurrent platinum-sensitive ovarian cancer treated with platinum-based combination chemotherapy regimens: A graphical approach to trial adverse event reporting. European Journal of Cancer, 2021, 148, pp.251-259. ⟨10.1016/j.ejca.2021.02.006⟩. ⟨hal-03236358⟩
12
View
0
Download